Pieter de Geus

Director/Board Member at Neuroplast BV

Health Technology

Profile

Pieter de Geus currently works at Prothya Biosolutions Belgium BV, as Director from 2020, Alveron Pharma BV, as Member-Supervisory Board, and Neuroplast BV, as Member-Supervisory Board from 2021.

Pieter de Geus active positions

Companies	Position	Start
Neuroplast BV Neuroplast BV BiotechnologyHealth Technology Neuroplast BV is a Dutch stem cell technology company that focuses on developing autologous cell products for the treatment of primarily inflammation-driven neurological disorders. Neuroplast is located in Brightlands Chemelot Campus in the Netherlands. The company's transformative treatment, Neuro-cellsò, is currently being tested for traumatic spinal cord injury (TSCI) and aims to reduce the irreversible impact of TSCI during the crucial first phase. The company was founded in August 2014 by physician De Munter and neurologist Erik Wolters, and current investors include Invest, Brightlands Venture Partners, and Liof NV. Johannes de Munter has been the CEO of the company since 2016.	Director/Board Member	20/10/2021
Alveron Pharma BV Alveron Pharma BV Pharmaceuticals: MajorHealth Technology Alveron Pharma BV is a Dutch company that develops cyclodextrin-based drugs. The company is based in Nijmegen, Netherlands. The company was founded in 2019. Ben Nichols has been the CEO of the company since 2019.	Director/Board Member	-
Prothya Biosolutions Belgium BV Prothya Biosolutions Belgium BV BiotechnologyHealth Technology Prothya Biosolutions Belgium BV is a Belgian company that was founded in 1997. The private company is based in Brussels, Belgium. The company manufactures plasma and pharmaceutical raw materials and operate as blood transfusion centers and organ banks.	Director/Board Member	30/12/2020

All active positions of Pieter de Geus

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Pieter de Geus's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Neuroplast BV Neuroplast BV BiotechnologyHealth Technology Neuroplast BV is a Dutch stem cell technology company that focuses on developing autologous cell products for the treatment of primarily inflammation-driven neurological disorders. Neuroplast is located in Brightlands Chemelot Campus in the Netherlands. The company's transformative treatment, Neuro-cellsò, is currently being tested for traumatic spinal cord injury (TSCI) and aims to reduce the irreversible impact of TSCI during the crucial first phase. The company was founded in August 2014 by physician De Munter and neurologist Erik Wolters, and current investors include Invest, Brightlands Venture Partners, and Liof NV. Johannes de Munter has been the CEO of the company since 2016.	Health Technology
Alveron Pharma BV Alveron Pharma BV Pharmaceuticals: MajorHealth Technology Alveron Pharma BV is a Dutch company that develops cyclodextrin-based drugs. The company is based in Nijmegen, Netherlands. The company was founded in 2019. Ben Nichols has been the CEO of the company since 2019.	Health Technology
Prothya Biosolutions Belgium BV Prothya Biosolutions Belgium BV BiotechnologyHealth Technology Prothya Biosolutions Belgium BV is a Belgian company that was founded in 1997. The private company is based in Brussels, Belgium. The company manufactures plasma and pharmaceutical raw materials and operate as blood transfusion centers and organ banks.	Health Technology

See company connections

Stock Market
Insiders
Pieter de Geus